Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Issue: Mar/Apr 2021 - Volume 25, Number 2
View All Articles in Issue
Page(s): 145
Download in electronic PDF format for $75
Abstract: A formulation for preparing Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords: Loyd V. Allen Jr., PhD, RPh, formulation, levodopa, carbidopa, parkinsonian syndrome, parkinsonism, decarboxylase inhibitor, stability
Related Categories: EXCIPIENTS, FORMULATIONS, DOSAGE FORMS/DRUG CARRIERS, MUSCULOSKELETAL DISORDERS, NEUROLOGY